5 terminated, 4 completed, 2 unknown, 2 withdrawn. 5 Not applicable, 5 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 2, Unknown 2, Withdrawn 1 |
| Phase 1 | 5 | Terminated 3, Completed 1, Withdrawn 1 |
| Phase 2 | 5 | Terminated 3, Recruiting 1, Withdrawn 1 |
Follow Cancer of Ovary: new trials by email Literature Review of Cancer of Ovary trials Research Report on Cancer of Ovary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Tart Cherry Juice - Breast Cancer, Breast Cancer Stage I | Phase 2 | Recruiting | University of California, Davis | 86 | 2024-08-15 | 2026-03-04 |
| Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy Promitil - Cancer of Ovary, Pancreatic Ductal Adenocarcinoma | Phase 2 | Terminated | Lipomedix Pharmaceuticals Inc. | 19 | 2024-06-13 | 2026-01-09 |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer | Phase 1 | Terminated | Nuvation Bio Inc. | 82 | 2022-03-29 | 2025-11-06 |
| Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer chemotherapy, targeted therapeutics, immunotherapy, IFRT, IMRT or SBRT - Ovarian Cancer, Neoplasm, Ovarian | Not applicable | Unknown | Xi'an Jiaotong University | 150 | 2021-10-10 | 2021-09-28 |
| Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients Cases for patients diagnosed with breast cancer, colonrectal cancer, ovarian cancer and endometrial cancer - Breast Cancer, Colorectal Cancer | Not applicable | Unknown | China Medical University Hospital | 300 | 2020-05-18 | 2023-02-08 |
| The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients Logotherapy - Cancer of Ovary, Endometrium Cancer | Not applicable | Completed | Akdeniz University | 68 | 2019-03-25 | 2022-02-18 |
| The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer Oregovomab, Poly ICLC - Cancer of Ovary, Neoplasms, Ovarian | Phase 1 | Terminated | CanariaBio Inc. | 10 | 2017-05-30 | 2020-12-22 |
| Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) Radiation Therapy, Cancer | Completed | DxTerity Diagnostics | 16 | 2017-04-06 | 2024-08-07 | |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors MEDI4736 - Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer | Phase 2 | Terminated | Washington University School of Medicine | 4 | 2016-09-12 | 2018-11-06 |
| Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids fluid sample - Cancer of Ovary | Not applicable | Withdrawn | Shaare Zedek Medical Center | 2016-05-01 | 2017-04-27 | |
| MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer MRI-guided SBRT, EORTC QLQ-C30 Questionnaire, EORTC QLQ-OV28 Questionnaire - Cancer of Ovary, Cancer of the Ovary | Phase 1 | Completed | Washington University School of Medicine | 10 | 2015-12-02 | 2019-01-17 |
| Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines Cisplatin + celecoxib + DC vaccine, Cisplatin + CKM + Celecoxib + DC Vaccine - Cancer of Ovary, Cancer of the Ovary | Phase 1 / Phase 2 | Withdrawn | Roswell Park Cancer Institute | 2015-09-04 | 2026-07-08 | |
| Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer Fenretinide/LXS + Ketoconazole - Ovarian Cancer, Cancer of Ovary | Phase 1 / Phase 2 | Terminated | South Plains Oncology Consortium | 12 | 2012-02-01 | 2020-08-27 |
| Validation of a Laparoscopic Score to Predict the Chance of Optimal Cytoreduction in Advanced Ovarian Cancer Patients Diagnostic laparoscopy - Cancer of Ovary | Not applicable | Completed | Catholic University of the Sacred Heart | 163 | 2010-03-01 | 2012-05-22 |
Ovarian Neoplasms (14) · Breast Neoplasms (4) · Pancreatic Neoplasms (3) · Colorectal Neoplasms (2) · Endometrial Neoplasms (2) · Kidney Neoplasms (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Prostatic Neoplasms (2) · Uterine Cervical Neoplasms (2) · Anus Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1)
Adnexal Diseases (14) · Endocrine Gland Neoplasms (14) · Endocrine System Diseases (14) · Female Urogenital Diseases (14) · Female Urogenital Diseases and Pregnancy Complications (14) · Genital Diseases (14) · Genital Diseases, Female (14) · Genital Neoplasms, Female (14) · Gonadal Disorders (14) · Neoplasms by Site (14) · Ovarian Diseases (14) · Urogenital Diseases (14) · Urogenital Neoplasms (14) · Neoplasms (12) · Breast Diseases (4)
Celecoxib (1) · Cisplatin (1) · Creatine Kinase, MM Form (1) · Drug Therapy (1) · Fenretinide (1) · Immunotherapy (1) · Ketoconazole (1) · Laparoscopy (1) · Logotherapy (1) · Radiosurgery (1) · Radiotherapy, Intensity-Modulated (1) · durvalumab (1) · enzalutamide (1) · olaparib (1) · oregovomab (1)
Washington University School of Medicine (2) · Akdeniz University (1) · CanariaBio Inc. (1) · Catholic University of the Sacred Heart (1) · China Medical University Hospital (1) · DxTerity Diagnostics (1) · Lipomedix Pharmaceuticals Inc. (1) · Nuvation Bio Inc. (1) · Roswell Park Cancer Institute (1) · Shaare Zedek Medical Center (1) · South Plains Oncology Consortium (1) · University of California, Davis (1) · Xi'an Jiaotong University (1)
United States (8) · Australia (1) · China (1) · Israel (1) · Taiwan (1) · Turkey (Türkiye) (1)
Amichai Meirovitz, MD (1) · Anna Fagotti, MD PhD (1) · Barry J Maurer, MD, PhD (1) · Christopher Nicodemus, MD FACP (1) · Clifford Robinson, M.D. (1) · Eve Rodler, MD (1) · Francesco Fanfani, MD (1) · Giovanni Scambia, MD (1) · Jayanthi Lea, MD (1) · Nirit Yarom, MD (1) · Ofer Purim, MD (1) · Ora Rosengarten, MD (1) · Ramaswamy Govindan, M.D. (1)
PMID 15781627, PMID 19774626, PMID 22330607, PMID 24023032, PMID 35046055, PMID 37642347
P01CA132714 (1)